Martilias Farrell, Ph.D.
Affiliations: | Pharmacology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Google:
"Martilias Farrell"Mean distance: 16.5 (cluster 23) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor| Bryan L. Roth | grad student | 2013 | UNC Chapel Hill | |
| (Pharmacosynthetics and the Cell-Type-Specific Control of Neuronal Signaling.) | ||||
| David P. Siderovski | grad student | 2013 | UNC Chapel Hill (Physics Tree) | |
| (Pharmacosynthetics and the Cell-Type-Specific Control of Neuronal Signaling.) | ||||
| Warren H. Meck | post-doc | Duke | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Halvorsen M, Huh R, Oskolkov N, et al. (2020) Increased burden of ultra-rare structural variants localizing to boundaries of topologically associated domains in schizophrenia. Nature Communications. 11: 1842 |
| Farrell M, Lichtenstein M, Crowley J, et al. (2019) THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA European Neuropsychopharmacology. 29: S1006-S1007 |
| Farrell MS, McCorvy JD, Huang XP, et al. (2016) In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. Plos One. 11: e0150602 |
| Huang XP, Karpiak J, Kroeze WK, et al. (2015) Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature |
| Urban DJ, Zhu H, Marcinkiewcz CA, et al. (2015) Elucidation of the Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Farrell MS, Werge T, Sklar P, et al. (2015) Evaluating historical candidate genes for schizophrenia. Molecular Psychiatry. 20: 555-62 |
| Farrell MS, Pei Y, Wan Y, et al. (2013) A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 854-62 |
| Farrell MS, Roth BL. (2013) Pharmacosynthetics: Reimagining the pharmacogenetic approach. Brain Research. 1511: 6-20 |
| Allen JA, Yadav PN, Setola V, et al. (2011) Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo. Translational Psychiatry. 1: e33 |
| Yadav PN, Kroeze WK, Farrell MS, et al. (2011) Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo. The Journal of Pharmacology and Experimental Therapeutics. 339: 99-105 |